Understanding and Applying New Advances, Based on New Receptor Targets and MOA, to Management of Generalized Tonic-Clonic Seizures (GTCS): Which Agent? How Soon? In What Sequence? Why?

Understanding and Applying New Advances, Based on New Receptor Targets and MOA, to Management of Generalized Tonic-Clonic Seizures (GTCS): Which Agent? How Soon? In What Sequence? Why?


Published

October 3, 2016

Created by

CMEducation Resources symposium